Skip to content

National Science Foundation (NSF) and NASA COI Policies

The NSF and NASA requires disclosure of significant financial interests by investigators receiving support for research either directly or via subaward. NSF's conflict of interest policy can be found in the NSF Proposal and Award Policies and Procedures Guide, Chapter IX - Grantee Standards. NASA's conflict of interest policy can be found here

Applicants to NSF and NASA must disclose project-related financial interests for themselves and all other project investigators at the proposal submission stage. This requirement also applies to subawards, to other federal non-PHS agencies, and to other agencies that have adopted the NSF requirements.

At the proposal stage the Principal Investigator (PI) must fill out the Conflict of Interest screening questions in SPO's Proposal Submission Request webform on behalf of all investigators that will be involved in the project. 

If any investigator prompts the PI to respond “yes” to any of the screening questions, the investigator will be required to complete and submit the NSF/NASA Financial Disclosure Form to the COI Office at for review prior to the award being released.

To Whom does the National Science (NSF) and NASA Conflict of Interest (COI) policy apply?

The NSF and NASA requires conflict of interest disclosures from all investigators who are defined as the principal investigator, co-principal investigators/co-project directors, and any other person at the organization who is responsible for the design, conduct, or reporting of research or educational activities funded or proposed for funding by NSF.”

What must be reported under the NSF/ NASA COI policies?

All investigators must disclose any “Significant Financial Interest” (SFI) and/or “Related Financial Interest” (RFI) of themselves, spouse, registered domestic partner, and dependent child(ren) where that financial interest may be: 1) affected by the research being conducted or, 2) in any organization that would reasonably appear to be affected by or benefit from the research being conducted.

What is a “Significant Financial Interest”?

Significant Financial Interest is defined as anything of monetary value including, but not limited to:

  • Salary, income, honoraria, royalties, dividends, consulting, loans, or other payment or consideration with value (including payments made to the University of California Health Sciences Compensation Plans and e.g., equipment loans) from any business, public, or nonprofit entity exceeding $10,000 during the prior twelve months, aggregated for the Investigator, spouse, dependent child(ren), and registered domestic partner. Equity interest (stock, stock options, real estate, etc.) that exceeds $10,000 or 5% ownership.
  • Equity interest (stock, stock options, real estate) that exceeds $10,000 or 5% ownership.
  • Management position such as board member, director, officer, partner, or trustee held by the Investigator.
  • Intellectual property interest held by the Investigator, spouse, dependent child(ren), or registered domestic partner assigned or to be assigned to a party other than the Regents.

Note: Income from seminars, lectures, teaching engagements, or service on advisory committees or review panels (e.g., NIH Peer Review) for public or private nonprofit entities is not disclosable. Payments made to the Investigator by the Regents are not disclosable.

What is excluded from disclosure/What is not a “Significant Financial Interest”?

  • Salary, royalties or other remuneration from the proposing organization;
  • Any ownership interests in the organization, if the organization is an applicant under the Small Business Innovation Research Program or Small Business Technology Transfer Program;
  • Income from seminars, lectures, or teaching engagements sponsored by public or non-profit entities;
  • Income from service on advisory committees or review panels for public or nonprofit entities;
  • An equity interest that, when aggregated for the investigator and the investigator’s spouse and dependent children, meets both of the following tests: does not exceed $10,000 in value as determined through reference to public prices or other reasonable measures of fair market value, and does not represent more than a 5% ownership interest in any single entity; or
  • Salary, royalties or other payments that, when aggregated for the investigator and the investigator’s spouse and dependent children, are not expected to exceed $10,000 during the prior twelve-month period.

What is a “Related Financial Interest”?

Related Financial Interest is defined as work performed under a sponsored project, which results would appear to affect the Investigator’s SFI; the following are considered RFIs:

  • Results of project being carried out by Investigator, which would be relevant to development, manufacturing, or improvement of product or service of entity in which Investigator has a SFI.
  • Investigator financial interest in an entity, which might manufacture or commercialize drug, device, procedure, or any other product used in the project or that will predictably result from the project.
  • Investigator consulting income from a single entity that exceeded $10,000 during the prior twelve months; and the financial interests of that entity, or the Investigator’s financial interest related to consulting for that entity, would reasonably appear to be affected by the research to be conducted.
  • Entity where financial interests lie is proposed as a subcontractor, consortium member, supplier of goods, lessor, or otherwise involved with the sponsored project.

When are disclosures required?

COI disclosures must be made at the time of project proposal and be updated annually, or whenever new reportable interests are obtained. Each disclosure must be reviewed before funds may be spent.